Middle East and Africa Contrast and Imaging Agents in Interventional X-ray Market Industry Trends Forecast to 2026

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 OBJECTIVES OF THE STUDY
• 1.2 MARKET DEFINITION
• 1.3 OVERVIEW OF MIDDLE EAST & AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET
• 1.4 CURRENCY AND PRICING
• 1.5 LIMITATION
• 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

• 2.1 MARKETS COVERED
• 2.2 GEOGRAPHIC SCOPE
• 2.3 YEARS CONSIDERED FOR THE STUDY
• 2.4 CURRENCY AND PRICING
• 2.5 RESEARCH METHODOLOGY
• 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
• 2.7 DBMR MARKET CHALLENGE MATRIX
• 2.8 MARKET APPLICATION COVERAGE GRID
• 2.9 DBMR VENDOR SHARE ANALYSIS
• 2.10 SECONDARY SOURCES
• 2.11 ASSUMPTIONS

3 MARKET OVERVIEW

• 3.1 DRIVERS
  • 3.1.1 RISING NUMBER OF CHRONIC DISEASES
  • 3.1.2 RISING AGING POPULATION
  • 3.1.3 GROWING NUMBER OF DIAGNOSTIC CENTERS
  • 3.1.4 INCREASE IN THE RESEARCH AND DEVELOPMENTAL ACTIVITIES OF CONTRAST AGENTS
• 3.2 RESTRAINT
  • 3.2.1 SIDE EFFECTS ASSOCIATED WITH CONTRAST AGENTS
• 3.3 OPPORTUNITIES
  • 3.3.1 RISING HEALTHCARE EXPENDITURE
  • 3.3.2 INCREASE IN NUMBER OF PUBLIC AND PRIVATE HOSPITALS
• 3.4 CHALLENGE
  • 3.4.1 LACK OF AWARENESS REGARDING THE PROPER DOSAGE OF CONTRAST AGENT

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 KEY PRIMARY INSIGHTS

7 MIDDLE EAST & AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE

• 7.1 OVERVIEW
• 7.2 IODINATED CONTRAST MEDIA
• 7.3 BARIUM-BASED CONTRAST MEDIA
• 7.4 MICROBUBBLE CONTRAST MEDIA
• 7.5 GOLD NANOPARTICLE CONTRAST AGENTS
• 7.6 OTHERS

8 MIDDLE EAST & AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION

• 8.1 OVERVIEW
• 8.2 CARDIOLOGY
  • 8.2.1 PERCUTANEOUS CORONARY INTERVENTION
  • 8.2.2 STRUCTURAL HEART DISEASE
  • 8.2.3 CONGENITAL HEART DISEASE
  • 8.2.4 ELECTROPHYSIOLOGY
• 8.3 GASTROENTEROLOGY
• 8.4 NEUROLOGY
• 8.5 ONCOLOGY
• 8.6 UROLOGY
• 8.7 GENERAL SURGERY

9 MIDDLE EAST & AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER

• 9.1 OVERVIEW
• 9.2 IMAGING CENTERS
• 9.3 HOSPITAL
• 9.4 CLINICS
• 9.5 DIAGNOSTIC CENTER
• 9.6 AMBULATORY SURGICAL CENTERS
• 9.7 PRIVATE PRACTICES

10 MIDDLE EAST & AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY GEOGRAPHY

• 10.1 MIDDLE EAST & AFRICA
  • 10.1.1 SOUTH AFRICA
  • 10.1.2 REST OF MIDDLE EAST & AFRICA
  • 10.1.3 EGYPT
  • 10.1.4 SAUDI ARABIA
  • 10.1.5 UNITED ARAB EMIRATES
  • 10.1.6 ISRAEL

11 MIDDLE EAST & AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, COMPANY LANDSCAPE

• 11.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

12 COMPANY PROFILES

• 12.1 BRACCO
  • 12.1.1 COMPANY SNAPSHOT
  • 12.1.2 GEOGRAPHICAL PRESENCE
  • 12.1.3 COMPANY SHARE ANALYSIS
  • 12.1.4 PRODUCT PORTFOLIO
  • 12.1.5 RECENT DEVELOPMENTS
• 12.2 GENERAL ELECTRIC COMPANY
  • 12.2.1 COMPANY SNAPSHOT
  • 12.2.2 REVENEUE ANALYSIS
  • 12.2.3 COMPANY SHARE ANALYSIS
  • 12.2.4 PRODUCT PORTFOLIO
  • 12.2.5 RECENT DEVELOPMENTS
• 12.3 GUERBET
  • 12.3.1 COMPANY SNAPSHOT
  • 12.3.2 REVENEUE ANALYSIS
  • 12.3.3 COMPANY SHARE ANALYSIS
  • 12.3.4 PRODUCT PORTFOLIO
  • 12.3.5 RECENT DEVELOPMENTS
• 12.4 FUJIFILM VISUALSONICS INC.
  • 12.4.1 COMPANY SNAPSHOT
  • 12.4.2 GEOGRAPHICAL PRESENCE
  • 12.4.3 PRODUCT PORTFOLIO
  • 12.4.4 RECENT DEVELOPMENT
• 12.5 IMAX
  • 12.5.1 COMPANY SNAPSHOT
  • 12.5.2 GEOGRAPHICAL PRESENCE
  • 12.5.3 PRODUCT PORTFOLIO
  • 12.5.4 RECENT DEVELOPMENT
• 12.6 J.B. CHEMICALS & PHARMACEUTICALS LTD.
  • 12.6.1 COMPANY SNAPSHOT
  • 12.6.2 REVENUE ANALYSIS
  • 12.6.3 PRODUCT PORTFOLIO
  • 12.6.4 RECENT DEVELOPMENT
• 12.7 JODAS EXPOIM
  • 12.7.1 COMPANY SNAPSHOT
  • 12.7.2 GEOGRAPHICAL PRESENCE
  • 12.7.3 PRODUCT PORTFOLIO
  • 12.7.4 RECENT DEVELOPMENTS
• 12.8 LANTHEUS MEDICAL IMAGING, INC.
  • 12.8.1 COMPANY SNAPSHOT
  • 12.8.2 REVENUE ANALYSIS
  • 12.8.3 PRODUCT PORTFOLIO
  • 12.8.4 RECENT DEVELOPMENTS
• 12.9 NANO THERAPEUTICS PVT. LTD.
  • 12.9.1 COMPANY SNAPSHOT
  • 12.9.2 GEOGRAPHICAL PRESENCE
  • 12.9.3 PRODUCT PORTFOLIO
  • 12.9.4 RECENT DEVELOPMENT
• 12.10 NOVALEK PHARMACEUTICALS PVT. LTD.
  • 12.10.1 COMPANY SNAPSHOT
  • 12.10.2 GEOGRAPHICAL PRESENCE
  • 12.10.3 PRODUCT PORTFOLIO
  • 12.10.4 RECENT DEVELOPMENT
• 12.11 TAEJOON PHARM
  • 12.11.1 COMPANY SNAPSHOT
  • 12.11.2 GEOGRAPHICAL PRESENCE
  • 12.11.3 PRODUCT PORTFOLIO
  • 12.11.4 RECENT DEVELOPMENT
• 12.12 UNIJULES LIFE SCIENCES LTD.
  • 12.12.1 COMPANY SNAPSHOT
  • 12.12.2 PRODUCT PORTFOLIO
  • 12.12.3 RECENT DEVELOPMENT

13 QUESTIONNAIRE

14 RELATED REPORTS